Meta-Analysis: Change in Albuminuria as a Surrogate Endpoint for Progression of Kidney Disease

Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials – The Lancet Endocrinology & Diabetes (link to abstract – $ for full-text)

Related Study: Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies – The Lancet Endocrinology & Diabetes (link to abstract – $ for full-text)

Commentaries: First Reports from Ambitious Workshop Published in The Lancet Diabetes and Endocrinology – National Kidney Foundation (free) AND Novel Albuminuria Endpoints May Improve CKD Progression Trials – Renal & Urology News (free)